Ratings by RBC Capital (Ryan Halsted)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/29/2026 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 9/25/2026 | Charles River Labs | CRL | Maintain | Outperform (N/A) |
|
Details | ||
| 9/8/2026 | Cencora Inc | COR | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/19/2026 | Cencora Inc | COR | New Coverage | Sector Perform (N/A) |
312.52 (340.54) |
8.97% | Details | |
| 8/19/2026 | McKesson | MCK | New Coverage | Sector Perform (N/A) |
859.92 (1016.91) |
18.26% | Details | |
| 8/19/2026 | Cardinal Health | CAH | New Coverage | Outperform (N/A) |
235.66 (256.75) |
8.95% | Details | |
| 8/6/2026 | Medline Inc | MDLN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2026 | Charles River Labs | CRL | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2026 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 7/24/2026 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2026 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2026 | Healthcare Services Group | HCSG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/13/2026 | Charles River Labs | CRL | New Coverage | Outperform (N/A) |
175.65 (328.72) |
87.14% | Details | |
| 3/3/2026 | Medpace | MEDP | New Coverage | Outperform (N/A) |
451.76 (636.26) |
40.84% | Details | |
| 3/3/2026 | Healthcare Services Group | HCSG | New Coverage | Sector Perform (N/A) |
21.77 (21.68) |
-0.41% | Details | |
| 3/3/2026 | IQVIA Holdings | IQV | New Coverage | Outperform (N/A) |
178.81 (271.01) |
51.56% | Details | |
| 2/26/2026 | Medline Inc | MDLN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2026 | Evolent Health | EVH | Maintain | (N/A) |
|
Details | ||
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Outperform (N/A) |
41.25 (35.23) |
-14.59% | Details |
